Darapladib, an inhibitor of Lp-PLA2, sensitizes cancer cells to ferroptosis by remodeling lipid metabolism
Mihee Oh(Korea Research Institute of Bioscience and Biotechnology), Eun‐Woo Lee(Korea Research Institute of Bioscience and Biotechnology)
Cited by 2
Related Papers
The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism
|Nature Communications|2023|86
FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner
|Cell Death and Disease|2023|53
Nurr1 performs its anti-inflammatory function by regulating RasGRP1 expression in neuro-inflammation
|Scientific Reports|2020|33